Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital-Reference-Cited by-同舟云学术

Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital

Published:2017-01-17 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Meng Xiujuan,Liu Sidi,Duan Juping,Huang Xun,Zhou Pengcheng,Xiong Xinrui,Gong Ruie,Zhang Ying,Liu Yao,Fu Chenchao,Li Chunhui,Wu Anhua

Funder

Hunan Provincial Health and Family Planning Commission

Young Scientists Fund of Xiangya Hospital

Xiangya Sinobio way Health Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-2176-9.pdf

Reference34 articles.

1. Feng Y, Yang P, Xie Y, Wang X, McNally A, Zong Z. Escherichia coli ofsequence type 3835 carrying bla NDM-1, bla CTX-M-15, bla CMY-42 and bla SHV-12. Sci Rep. 2015;5:12275.

2. Lartigue MF, Poirel L, Poyart C, Reglier-Poupet H, Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis. 2007;13(2):315–7.

3. Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, et al. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit. Am J Epidemiol. 2016;183(5):471–9.

4. Jeon M, Choi S, Kwak YG, Chung J, Lee S, Jeong J, Woo JH, Kim YS. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis. 2008;62(4):402–6.

5. Gulmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, Kocagoz S, Uzun O, Hascelik G, Livermore DM. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents. 2008;31(6):523–6.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical risk factors and outcomes of carbapenem-resistant Escherichia coli nosocomial infections in a Chinese teaching hospital: a retrospective study from 2013 to 2020;Microbiology Spectrum;2024-07-02

2. Containment of carbapenem-resistant Enterobacterales colonisations and infections: Results from an integrated infection control intervention in a large hospital trust of northern Italy;American Journal of Infection Control;2024-01

3. Extended Spectrum β-Lactamase-Producing Enterobacterales of Shrimp and Salmon Available for Purchase by Consumers in Canada—A Risk Profile Using the Codex Framework;Antibiotics;2023-09-06

4. Risk factors and outcomes of carbapenem-resistant Escherichia coli nosocomial infections in a Chinese teaching hospital: A retrospective study from 2013 to 2020;2023-09-01

5. The impact of COVID-19 pandemic on hand hygiene compliance of healthcare workers in a tertiary hospital in East China;Frontiers in Medicine;2023-06-22